Q9BYF1 (ACE2_HUMAN) Homo sapiens (Human)

Angiotensin-converting enzyme 2 UniProtKBInterProSTRINGInteractive Modelling

805 aa; Sequence (Fasta)

Molecule Processing
Processed angiotensin-converting enzyme 2

Sequence Features

Add
 375Proton acceptor
 505Proton donor
 374Zinc; catalytic
 378Zinc; catalytic
 402Zinc; catalytic
 26K -> R (polymorphism; dbSNP:rs4646116) VAR_023082 dbSNP
 468I -> V (polymorphism) VAR_083726
 638N -> S (polymorphism; dbSNP:rs183135788) VAR_023083 dbSNP
 720N -> D (polymorphism) VAR_083727
 741-761Helical
 133-141
 344-361
 530-542
 21-606Peptidase M2, peptidyl-dipeptidase A
IPR001548PF01401
 617-770Collectrin domain
IPR031588PF16959

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRange
ACE2-B0AT1 complex Heteromer
Q695T7;
14×NAG; 10×NAG;3PH;ZN;6m1820-768
Assess
ACE2-B0AT1 complex, open conformation Heteromer
Q695T7;
6m1d21-768
Assess
The 2019-nCoV RBD/ACE2-B0AT1 complex Heteromer
P0DTC2; Q695T7;
14×NAG;NAG; 10×NAG;LEU;ZN;6m1721-768
Assess
Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) Heteromer
NAG;CL;ZN;1r4219-615
Assess
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 Heteromer
P0DTC2;
ZN;CL;NAG;6m0j19-615
Assess
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus huma… Heteromer
P59594; Q56NL1;
NDG;ZN;CL;NAG;3d0g19-615
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus human … Heteromer
P59594;
ZN;CL;3sci19-615
Assess
Crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS coronavirus cive… Heteromer
P59594; Q56NL1;
NDG;ZN;CL;NAG;3d0i19-615
Assess
Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor Heteromer
P59594;
NAG;NAG;ZN;CL;2ajf19-615
Assess
Inhibitor Bound Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) Heteromer
NAG;CL;ZN;XX5;1r4l19-615
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … Heteromer
P59594;
ZN;CL;3scj19-615
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … Heteromer
P59594; Q56NL1;
ZN;CL;3sck19-615
Assess
Crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain co… Heteromer
P59594; Q56NL1;
ZN;CL;3scl19-615
Assess
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus cive… Heteromer
P59594; Q56NL1;
NDG;ZN;CL;NAG;3d0h19-615
Assess
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39 Heteromer
P0DTC2;
NAG;NAG;NAG;NAG;ZN;SO4;7dmu19-615
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
P59594;
6acg19-615
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
P59594;
6acj19-615
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
P59594;
6ack19-615
Assess
SARS-CoV-2 S-ACE2 complex Heteromer
P0DTC2;
18×NAG; 36×NAG;7df419-615
Assess
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2 Heteromer
P0DTC2;
NAG;ZN;6lzg19-614
Assess
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2 Heteromer
P0DTC2; P59594;
NAG;NAG;ZN;CL;EDO;NAG;6vw119-614
Assess
Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human … Heteromer
Q6Q1S2;
NAG;3kbh19-614
Assess
ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2… Heteromer
P0DTC2;
NAG;NAG;7kmb19-614
Assess
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 Heteromer
P0DTC2;
NAG; 46×NAG;7knb19-614
Assess
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4 Heteromer
P0DTC2;
NAG; 53×NAG;7kmz19-614
Assess
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 Heteromer
P0DTC2;
NAG; 55×NAG;7kms19-614
Assess
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5 Heteromer
P0DTC2;
NAG; 44×NAG;7kne19-614
Assess
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5 Heteromer
P0DTC2;
NAG; 48×NAG;7knh19-614
Assess
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5 Heteromer
P0DTC2;
NAG; 56×NAG;7kni19-614
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction Heteromer
P0DTC2;
7a9519-613
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction Heteromer
P0DTC2;
7a9619-613
Assess
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound Heteromer
P0DTC2;
7a9719-613
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound Heteromer
P0DTC2;
23×NAG;ZN;7a9419-613
Assess
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) Heteromer
P0DTC2;
NAG;NAG;ZN;7a9119-613
Assess
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound Heteromer
P0DTC2;
7a9819-613
Assess
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) Heteromer
P0DTC2;
NAG;NAG;ZN;7a9219-613
Assess
S protein of SARS-CoV-2 in complex bound with T-ACE2 Heteromer
P0DTC2;
35×NAG; 34×NAG;7ct521-615
Assess
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound Heteromer
P0DTC2;
17×NAG; 36×NAG;7kj221-613
Assess
SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound Heteromer
P0DTC2;
20×NAG; 40×NAG;7kj321-613
Assess
SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound Heteromer
P0DTC2;
24×NAG; 42×NAG;7kj421-613
Assess
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles Heteromer
P59594;
NAG;NAG; 11×NAG;NAG;6cs219-562
Assess
Importin alpha bound to the C-terminus of ACE2 Heteromer
P52293;
7jvo768-774
Assess

Homology models

Oligo-stateQMEANTemplateRangeSeq id (%)Ligands
Heteromer
P0DTC2;
-0.23 6m0j.1.A19-615
100.00ZN;
Assess
Heteromer
P0DTC2;
-0.45 6lzg.1.A20-613
100.00NAG;ZN;
Assess
Heteromer
P0DTC2;
-0.69 6vw1.2.A19-614
96.19EDO;
Assess
Heteromer
P0DTC2;
-1.95 7a94.1.D19-613
99.89NAG;ZN;
Assess
Heteromer
P0DTC2;
-3.98 6acg.1.D19-615
84.55
Assess